[(2-Thiophenesulfonylamino)methyl]-phosphonic acid mono-(benzyl)ester ammonium salt | 318462-75-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [(2-Thiophenesulfonylamino)methyl]-phosphonic acid mono-(benzyl)ester ammonium salt
• 英文别名: [(2-Thiophenesulfonylamino)methyl]-phosphonic acid mono-(benzyl) ester ammonium salt；azanium;phenylmethoxy-[(thiophen-2-ylsulfonylamino)methyl]phosphinate
• CAS: 318462-75-8
• 化学式: C₁₂H₁₃NO₅PS₂*H₄N
• 分子量: 364.383
• InChiKey: MGDJGJKCKHDLAI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.13
• 重原子数：
  22
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  133
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  [(2-Thiophenesulfonylamino)methyl]-phosphonic acid 、 苯甲醇 在 ammonium salt 、 氯仿 、 甲醇 、 ammonium hydroxide 作用下， 生成 [(2-Thiophenesulfonylamino)methyl]-phosphonic acid mono-(benzyl)ester ammonium salt
  参考文献：
  名称：

  Novel inhibitors of beta-lactamase

  摘要：

  本发明涉及细菌抗生素耐药性，特别是涉及克服细菌抗生素耐药性的组合物和方法。本发明提供了新型的β-内酰胺酶抑制剂，其在结构上与目前可获得的天然产物和半合成β-内酰胺酶抑制剂无关，并且不需要β-内酰胺药效团。本发明还提供了用于抑制细菌生长的药物组合物和方法。

  公开号：

  US20040029836A1

文献信息

• Novel Inhibitors of beta-lactamase
  申请人：MethylGene, Inc.

  公开号：US20040082546A1

  公开（公告）日：2004-04-29

  The invention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel &bgr;-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic &bgr;-lactamase inhibitors presently available, and which do not require a &bgr;-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.

  这项发明涉及细菌抗生素耐药性，特别是用于克服细菌抗生素耐药性的组合物和方法。该发明提供了新型β-内酰胺酶抑制剂，其在结构上与目前可用的天然产物和半合成β-内酰胺酶抑制剂无关，并且不需要β-内酰胺药效团。该发明还提供了用于抑制细菌生长的药物组合物和方法。
• [EN] SULFONAMIDOMETHYL PHOSPHONATE INHIBITORS OF beta -LACTAMASE<br/>[FR] INHIBITEURS SULFONAMIDOMETHYL-PHOSPHONATE DE LA beta -LACTAMASE
  申请人：METHYLGENE INC

  公开号：WO2001002411A1

  公开（公告）日：2001-01-11

  The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic β-lactamase inhibitors presently available, and which do not require a β-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.

  本发明涉及细菌抗生素抗性，特别是涉及克服细菌抗生素抗性的组合物和方法。本发明提供了新型β-内酰胺酶抑制剂，其与目前已有的天然产物和半合成β-内酰胺酶抑制剂在结构上没有关联，并且不需要β-内酰胺药效团。本发明还提供了用于抑制细菌生长的药物组合物和方法。
• Novel sulfonamidomethyl phosphonate inhibitors of beta-lactamase
  申请人：——

  公开号：US20040059115A1

  公开（公告）日：2004-03-25

  The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel &bgr;-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic &bgr;-lactamase inhibitors presently available, and which do not require a &bgr;-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.

  本发明涉及细菌抗生素耐药性，特别是涉及克服细菌抗生素耐药性的组合物和方法。本发明提供了新型β-内酰胺酶抑制剂，其与目前已有的天然产物和半合成β-内酰胺酶抑制剂结构上无关，且不需要β-内酰胺药效团。本发明还提供了用于抑制细菌生长的药物组合物和方法。
• Inhibitors of β-lactamase
  申请人：MethylGene Inc.

  公开号：US07259172B2

  公开（公告）日：2007-08-21

  The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic β-lactamase inhibitors presently available, and which do not require a β-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.

  该发明涉及细菌抗生素耐药性，特别是涉及克服细菌抗生素耐药性的组合物和方法。该发明提供了新颖的β-内酰胺酶抑制剂，其与目前可用的天然产物和半合成β-内酰胺酶抑制剂在结构上无关，并且不需要β-内酰胺药效团。该发明还提供了用于抑制细菌生长的制药组合物和方法。
• Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
  申请人：MethylGene, Inc.

  公开号：US06472406B1

  公开（公告）日：2002-10-29

  The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel &bgr;-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic &bgr;-lactamase inhibitors presently available, and which do not require a &bgr;-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.

  这段话的意思是：意图与细菌抗生素耐药性有关，特别是涉及克服细菌抗生素耐药性的组合物和方法。该发明提供了新颖的β-内酰胺酶抑制剂，其与目前已有的天然产物和半合成β-内酰胺酶抑制剂在结构上无关，且不需要β-内酰胺药效团。该发明还提供了用于抑制细菌生长的制药组合物和方法。